日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MiR-3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway

MiR-3116 通过靶向 FGFR1 并调节 FGFR1/PI3K/AKT 通路,增强胶质瘤细胞对替莫唑胺的敏感性

Shiqi Kong, Yingxiao Cao, Xin Li, Zhenzhong Li, Yuling Xin, Yan Meng

Lestaurtinib potentiates TRAIL-induced apoptosis in glioma via CHOP-dependent DR5 induction

来他替尼通过 CHOP 依赖的 DR5 诱导增强 TRAIL 诱导的胶质瘤细胞凋亡

Yingxiao Cao, Shiqi Kong, Yuling Xin, Yan Meng, Shuling Shang, Yanhui Qi